Granexin for diabetic foot ulcer

Press Release: FirstString Research, Inc. Announces the Achievement of Primary Endpoints in Three Phase 2 Clinical Trials of Granexin™ Gel for the Treatment of Chronic Wounds and Scar Reduction Positive Data on Novel Topical Peptide to be Presented at the International Gap Junction Conference 2013 Quote: FirstString Research, Inc. today announced that it will present positive data from three Phase 2 trials of GranexinTM Gel for the treatment of diabetic foot ulcers (DFUs), venous leg ulcers (VLUs) and for scar reduction at the upcoming International Gap Junction Conference (IGJC), July 13-18, 2013, in Charleston, SC

See more here:
Granexin for diabetic foot ulcer

Previous post:

Next post: